Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2005
10/12/2005EP1584628A2 Viral protein
10/12/2005EP1583830A2 Method for manufacturing recombinant polyclonal proteins
10/12/2005EP1583777A2 Methods of therapy and diagnosis using targeting of cells that express ly-9
10/12/2005EP1583771A2 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
10/12/2005EP1583558A2 Designed deimmunized monoclonal antibodies for protection against hiv exposure and treatment of hiv infection
10/12/2005EP1583550A2 Inhibition of pacap signalling for the prevention and treatment of thrombocytopenia
10/12/2005EP1583517A2 Methods and products for treating staphylococcal infections
10/12/2005EP1583504A2 Methods and compositions for the diagnosis, prognosis, and treatment of cancer
10/12/2005EP1583503A2 Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof
10/12/2005EP1468012A4 Biomolecule transduction motif mph-1-btm and the use thereof
10/12/2005EP1339867A4 Alterations in the long qt syndrome genes kvlqt1 and scn5a and methods for detecting same
10/12/2005EP1046038B1 Use of mass fingerprinting for identification of protein affinity ligands
10/12/2005EP0793723B1 New staphylokinase derivatives
10/12/2005EP0669979B1 C-c ckr-1, c-c chemokine receptor
10/12/2005CN1682111A Diagnosing tumorigenicity and determining resistance to the antineoplastic therapy
10/12/2005CN1681926A Human antihuman MCP-1 antibody and antibody fragment thereof
10/12/2005CN1681924A In vitro peptide expression library
10/12/2005CN1681918A Transplant acceptance inducing cells of monocytic origin and their preparation and use
10/12/2005CN1681845A Therapeutic uses of monoclonal antibodies to the angiotensin-II type-1 receptor
10/12/2005CN1681843A Parathyroid hormone-like polypeptides
10/12/2005CN1681838A Nogo受体拮抗剂 Nogo receptor antagonist
10/12/2005CN1681837A Method of purifying protein
10/12/2005CN1681531A Methods for the treatment of an infectious bacterial disease with an anti-lactone or lactone derived signal molecules antibody
10/12/2005CN1681529A Immunogenic compositions and diagnostic and therapeutic uses thereof
10/12/2005CN1680592A Diagnostic assay
10/12/2005CN1680581A Single clone antibody of antimutagen hepatitis B virus surface antigen
10/12/2005CN1680557A Penicillium marneffei CRG5 gene, its coding protein and use
10/12/2005CN1680554A Penicillium marneffei thymus resistant glubolin, its coding sequence and use
10/12/2005CN1680553A Penicillium marneffei 40S ribosomal protein S28, its coding sequence and use
10/12/2005CN1680450A Fusion protein, coding gene and use thereof
10/12/2005CN1680447A Neutralizing high affinity human monoclonal antibodies specific to respiratory syncytial virus f-protein
10/12/2005CN1680446A Extraction of immunoglobulin
10/12/2005CN1680445A Antithemolytic streptococcus, staphylococcus and candida albicans lgG antibody and preparation thereof
10/12/2005CN1680444A Monoclone antibody against virus of xiangshizhubanbo and its use
10/12/2005CN1680434A Streptococcus pneumoniae antigens
10/12/2005CN1680432A Viral protein
10/12/2005CN1680426A Purification method which prevents denaturation of an antibody
10/12/2005CN1680407A Preparation of triazoline artificial semi-antigen, antigen and antibody
10/12/2005CN1680406A Triazoline artificial semi-antigen, antigen, specific antibody and use thereof
10/12/2005CN1680405A Chlorpyrifos artificial semiantigen, antigen, antibody and use, synthesis of semiantigen
10/12/2005CN1679935A Method for treating fibrosis by utilizing integrin alpha 4 subunit antagonist
10/12/2005CN1679934A Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody
10/12/2005CN1222618C Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof
10/12/2005CN1222617C Chemotactic factor receptos 88-2B [CKR-3] and 88C and their antibodies
10/12/2005CN1222616C Novel human protein with cancer-inhibiting function and coding sequence thereof
10/12/2005CN1222540C Monoclonal antibodies anti-CD6 and their uses
10/12/2005CN1222539C Human receptor proteins, related reagents and methods
10/11/2005US6953841 Polypeptides having at least about 80% amino acid sequence identity to a PRO polypeptide lacking its associated signal peptide
10/11/2005US6953838 Urocortin-III and uses thereof
10/11/2005US6953836 PRO844 polypeptides
10/11/2005US6953681 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
10/11/2005US6953675 Landscaped antibodies and antibody fragments for clinical use
10/11/2005US6953670 Methods for identifying compounds capable of supplementing the biological activity of leptin
10/11/2005US6953667 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of autoimmune disease
10/11/2005US6953666 Immunoassay method, analysis using antibody to bind the amino acid, or protein that has undergone oxidation, contains sulfur- or selenium amino acids, detecting oxidative damage
10/11/2005US6953664 Genes and polynucleotides associated with ultraviolet radiation-mediated skin damage and uses thereof
10/11/2005US6953567 Radiolabeling peptides by reacting thiol-containing peptides with an F-18-bound labelling reagent which also has a group that is reactive with thiols; targeted to a tissue using bispecific antibodies
10/11/2005CA2341276C Human anti-factor ix/ixa antibodies
10/11/2005CA2140550C Cloning and expression of a human .alpha.(1,3)fucosyltransferase, fuct-vi
10/09/2005CA2501624A1 Cloning and expression of gonadotropin-releasing hormone (gnrh) receptors
10/06/2005WO2005093427A1 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 50 (gpr50)
10/06/2005WO2005093421A1 Enzyme immunoassay for identifying cathepsin k
10/06/2005WO2005093417A1 Assays for amphetamine and methamphetamine using stereospecific reagents
10/06/2005WO2005093068A1 Novel protein and promoter
10/06/2005WO2005093057A1 Truncated dance, dance complex and method of using these
10/06/2005WO2005093048A1 Cancerous disease modifying antibodies
10/06/2005WO2005092927A1 Receptor coupling agents and therapeutic uses thereof
10/06/2005WO2005092926A2 Reducing the risk of human and anti-human antibodies through v gene manipulation
10/06/2005WO2005092925A2 Immunoglobulin variants outside the fc region
10/06/2005WO2005092831A1 Assays for amphetamine and methamphetamine
10/06/2005WO2005092383A1 Preventive/remedy for respiratory diseases
10/06/2005WO2005092381A1 Use of emmprin antagonists for the treatment of diseases associated with excessive angiogenesis
10/06/2005WO2005092380A2 Uses of anti-ctla-4 antibodies
10/06/2005WO2005092378A2 Anti-vglut glutamate transporter antibodies for use in pain therapy
10/06/2005WO2005092377A1 Cytotoxicity mediation of cells evidencing surface expression of cd63
10/06/2005WO2005092376A1 Cytotoxicity mediation of cells evidencing surface expression of mcsp
10/06/2005WO2005092375A1 Cytotoxicity mediation of cells evidencing surface expression of cd44
10/06/2005WO2005092373A1 Method for amplifying therapeutic vaccine activity
10/06/2005WO2005092073A2 Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation
10/06/2005WO2005091856A2 Asthma-related anti-il-13 immunoglobulin derived proteins, compositions, methods and uses
10/06/2005WO2005091853A2 Methods and compositions for treating il-13 related pathologies
10/06/2005WO2005091805A2 Methods and compositions for inhibition of metastasis
10/06/2005WO2005077090A3 Improved methods of producing antibody conjugates
10/06/2005WO2005048938A3 Anti-pecam therapy for metastasis suppression
10/06/2005WO2005046720A3 Diagnosis, prognosis and treatment of pulmonary diseases using foxa2
10/06/2005WO2005017121A3 Mbcats as modifiers of the beta-catenin pathway and methods of use
10/06/2005WO2004094603A3 Transgenic mouse with simplified dh locus
10/06/2005WO2004084812A3 Tamandarin analogs and fragments thereof and methods of making and using
10/06/2005WO2004076618A9 Genetically modified non-human mammals and cells
10/06/2005WO2004032877A3 Compositions, organisms and methodologies employing a novel human kinase
10/06/2005US20050222392 Anti-idiotype anti-cea antibody molecules and its use as cancer vaccine
10/06/2005US20050222391 Method of constructing antibody
10/06/2005US20050222059 Egfrviii specific monoclonal antibody and egfrviii ribozymes and use to detect, treat or prevent egfrviii associated cancer
10/06/2005US20050222033 Receptor based antagonists and methods of making and using
10/06/2005US20050222011 Selectin ligands
10/06/2005US20050221500 Protein identification from protein product ion spectra
10/06/2005US20050221445 Useful as agents that inhibit virus infection of cells
10/06/2005US20050221440 Nucleic acid containing a reading frame with a first sequence encoding segments of the tumor associated antigen, PRAME (preferentially expressed antigen in melanoma); immunogenic; cluster sequences have affinity for a same Major Histocompatibility Complex receptor peptide binding cleft
10/06/2005US20050221438 antibodies that bind polypeptides that are prefrentially expressed by all mature NK cells, used for grafting enhancement, graft versus host (GvH) inhibition, graft versus tumor (GvT) stimulation, for the prevention or therapy of tumors and/or of microorganism infections
10/06/2005US20050221435 Biological material for preparing pharmaceutical compositions intended for treating mammals
1 ... 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 ... 1494